Studying telomere replication by Q-CO-FISH: The effect of telomestatin, a potent G-quadruplex ligand

Cytogenetic and Genome Research

Volumn 122, Issue 3-4, 2009, Pages 229-236

  Arnoult, N ^a   Shin Ya, K ^b   Londono Vallejo J A ^a  

^a INSTITUT CURIE   (France)

^b Japan Biological Information Research Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX; GUANOSINE; LIGAND; TELOMESTATIN;

ANIMAL CELL; ARTICLE; CHROMOSOME REPLICATION; CONTROLLED STUDY; DNA PROBE; DNA STRAND; DRUG EFFECT; DRUG PENETRATION; EMBRYO; FIBROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; MOUSE; MOUSE EMBRYO; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TELOMERE; TREATMENT DURATION;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL LINE; DNA; DNA REPLICATION; FIBROBLASTS; IN SITU HYBRIDIZATION, FLUORESCENCE; METAPHASE; MICE; NUCLEIC ACID HYBRIDIZATION; OXAZOLES; TELOMERASE; TELOMERE;

EID: 59649090705     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167808     Document Type: Article

References (49)

1. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J: Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318:798-801 (2007).
2. Bailey SM, Cornforth MN, Kurimasa A, Chen DJ, Goodwin EH: Strand-specific postreplicative processing of mammalian telomeres. Science 293:2462-2465 (2001).
3. Binz N, Shalaby T, Rivera P, Shin-ya K, Grotzer MA: Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells. Eur J Cancer 41:2873-2881 (2005).
4. Blackburn EH: The end of the (DNA) line. Nat Struct Biol 7:847-850 (2000).
5. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271-1274 (1997).
6. Cornforth MN, Eberle RL: Termini of human chromosomes display elevated rates of mitotic recombination. Mutagenesis 16:85-89 (2001).
7. Crabbe L, Verdun RE, Haggblom CI, Karlseder J: Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306:1951-1953 (2004).
8. Dai J, Carver M, Yang D: Polymorphism of human telomeric quadruplex structures. Biochimie 90:1172-1183 (2008).
9. Davis T, Singhrao SK, Wyllie FS, Haughton MF, Smith PJ, et al: Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. J Cell Sci 116:1349-1357 (2003).
10. De Cian A, Lacroix L, Douarre C, Temime-Smaali N, Trentesaux C, et al: Targeting telomeres and telomerase. Biochimie 90:131-155 (2008).
11. de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19:2100-2110 (2005).
12. Ding H, Schertzer M, Wu X, Gertsenstein M, Selig S, et al: Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 117:873-886 (2004).
13. Gilson E, Geli V: How telomeres are replicated. Nat Rev Mol Cell Biol 8:825-838 (2007).
14. Gilson E, Londoño-Vallejo A: Telomere length profiles in humans: all ends are not equal. Cell Cycle 6:2486-2494 (2007).
15. Gomez D, Paterski R, Lemarteleur T, Shin-Ya K, Mergny JL, Riou JF: Interaction of telomestatin with the telomeric single-strand overhang. J Biol Chem 279:41487-41494 (2004).
16. Gomez D, O'Donohue MF, Wenner T, Douarre C, Macadre J, et al: The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. Cancer Res 66:6908-6912 (2006a).
17. Gomez D, Wenner T, Brassart B, Douarre C, O'Donohue MF, et al: Telomestatin induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J Biol Chem 281:38721-38729 (2006b).
18. Goto M: Hierarchical deterioration of body systems in Werner's syndrome: implications for normal ageing. Mech Ageing Dev 98:239-254 (1997).
19. Graakjaer J, Der-Sarkissian H, Schmitz A, Bayer J, Thomas G, Kolvraa S, Londoño-Vallejo JA: Allele-specific relative telomere lengths are inherited. Hum Genet 119:344-350 (2006).
20. Gray MD, Shen JC, Kamath-Loeb AS, Blank A, Sopher BL, et al: The Werner syndrome protein is a DNA helicase. Nat Genet 17:100-103 (1997).
21. Hug N, Lingner J: Telomere length homeostasis. Chromosoma 115:413-425 (2006).
22. Hurley LH, Wheelhouse RT, Sun D, Kerwin SM, Salazar M, et al: G-quadruplexes as targets for drug design. Pharmacol Ther 85:141-158 (2000).
23. Kim MY, Gleason-Guzman M, Izbicka E, Nishioka D, Hurley LH: The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Cancer Res 63:3247-3256 (2003).
24. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, et al: Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5:685-691 (1996).
25. Lemarteleur T, Gomez D, Paterski R, Mandine E, Mailliet P, Riou JF: Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. Biochem Biophys Res Commun 323:802-808 (2004).
26. Li JL, Harrison RJ, Reszka AP, Brosh RM Jr, Bohr VA, et al: Inhibition of the Bloom's and Werner's syndrome helicases by G-quadruplex interacting ligands. Biochemistry 40:15194-15202 (2001).
27. Londoño-Vallejo JA: Telomere instability and cancer. Biochimie 90:73-82 (2008).
28. Londoño-Vallejo JA, DerSarkissian H, Cazes L, Thomas G: Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Res 29:3164-3171 (2001).
29. Londoño-Vallejo JA, Der-Sarkissian H, Cazes L, Bacchetti S, Reddel R: Alternative lengthening of telomeres is characterized by high rates of inter-telomeric exchange. Cancer Res 64:2324-2327 (2004).
30. Luu KN, Phan AT, Kuryavyi V, Lacroix L, Patel DJ: Structure of the human telomere in K+ solution: an intramolecular (3 + 1) G-quadruplex scaffold. J Am Chem Soc 128:9963-9970 (2006).
31. Mohaghegh P, Hickson ID: Premature aging in RecQ helicase-deficient human syndromes. Int J Biochem Cell Biol 34:1496-1501 (2002).
32. Mohaghegh P, Karow JK, Brosh RM Jr, Bohr VA, Hickson ID: The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res 29:2843-2849 (2001).
33. Oganesian L, Bryan TM: Physiological relevance of telomeric G-quadruplex formation: a potential drug target. Bioessays 29:155-165 (2007).
34. Olsen CM, Gmeiner WH, Marky LA: Unfolding of G-quadruplexes: energetic and ion and water contributions of G-quartet stacking. J Phys Chem B 110:6962-6969 (2006).
35. Opresko PL, Mason PA, Podell ER, Lei M, Hickson ID, et al: POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates. J Biol Chem 280:32069-32080 (2005).
36. Paeschke K, Simonsson T, Postberg J, Rhodes D, Lipps HJ: Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo. Nat Struct Mol Biol 12:847-854 (2005).
37. Paeschke K, Juranek S, Simonsson T, Hempel A, Rhodes D, Lipps HJ: Telomerase recruitment by the telomere end binding protein-beta facilitates G-quadruplex DNA unfolding in ciliates. Nat Struct Mol Biol 15:598-604 (2008).
38. Salas TR, Petruseva I, Lavrik O, Bourdoncle A, Mergny JL, et al: Human replication protein A unfolds telomeric G-quadruplexes. Nucleic Acids Res 34:4857-4865 (2006).
39. Salazar M, Thompson BD, Kerwin SM, Hurley LH: Thermally induced DNA RNA hybrid to G-quadruplex transitions: possible implications for telomere synthesis by telomerase. Biochemistry 35:16110-16115 (1996).
40. Salvati E, Leonetti C, Rizzo A, Scarsella M, Mottolese M, et al: Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest 117:3236-3247 (2007).
41. Sfeir AJ, Chai W, Shay JW, Wright WE: Telomere-end processing: the terminal nucleotides of human chromosomes. Mol Cell 18:131-138 (2005).
42. Shammas MA, Shmookler Reis RJ, Li C, Koley H, Hurley LH, et al: Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma. Clin Cancer Res 10:770-776 (2004).
43. Shay JW, Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26:867-874 (2005).
44. Shin-ya K, Wierzba K, Matsuo K, Ohtani T, Yamada Y, et al: Telomestatin a novel telomerase inhibitor from Streptomyces anulatus. J Am Chem Soc 123:1262-1263 (2001).
45. Silahtaroglu A, Pfundheller H, Koshkin A, Tommerup N, Kauppinen S: LNA-modified oligonucleotides are highly efficient as FISH probes. Cytogenet Genome Res 107:32-37 (2004).
46. Tauchi T, Shin-Ya K, Sashida G, Sumi M, Nakajima A, et al: Activity of a novel G-quadruplex-interactive telomerase inhibitor telomestatin (SOT-095) against human leukemia cells: involvement of ATM-dependent DNA damage response pathways. Oncogene 22:5338-5347 (2003).
47. Tauchi T, Shin-ya K, Sashida G, Sumi M, Okabe S, et al: Telomerase inhibition with a novel G-quadruplex-interactive agent telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene 25:5719-5725 (2006).
48. Wright WE, Shay JW: Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev 11:98-103 (2001).
49. Wu Y, Shin-ya K, Brosh RM Jr: FANCJ helicase defective in Fanconi anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol 28:4116-4128 (2008).